Long term response in a patient with neoplastic meningitis secondary to melanoma treated with 131I‐radiolabeled antichondroitin proteoglycan sulfate Mel‐14 F(ab′)2

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Cancer

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(20010501)91:9<1809::AID-CNCR1200>3.0.CO;2-LPMID 11335907
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.

  1997cited by this paper
• Principles and Applications

  1997cited by this paper
• Clinical outcome in aggressively treated meningeal carcinomatosis.

  1994cited by this paper
• Leptomeningeal metastases

  1994cited by this paper
• Treatment of leptomeningeal metastasis with intraventricular administration of depot cytarabine (DTC 101). A phase I study.

  1993cited by this paper
• Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group.

  1993cited by this paper
• Current concepts in leptomeningeal metastasis

  1992cited by this paper
• Radioimmunotherapy of intracerebral human glioma xenografts with 131I-labeled F(ab')2 fragments of monoclonal antibody Mel-14.

  1990cited by this paper
• Monoclonal antibody and F(ab')2 fragment delivery to tumor in patients with glioma: comparison of intracarotid and intravenous administration.

  1990cited by this paper
• A microcomputer algorithm for solving first-order compartmental models involving recycling.

  1989cited by this paper
• Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity.

  1989cited by this paper
• Comparative localization of murine monoclonal antibody Me1-14 F(ab')2 fragment and whole IgG2a in human glioma xenografts.

  1988cited by this paper
• The pharmacology and clinical use of methotrexate.

  1983cited by this paper
• Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients

  1982cited by this paper
• The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system.

  1981cited by this paper
• Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma. Radiation therapy oncology group brain metastases study I and II

  1980cited by this paper
• Common human melanoma-associated antigen(s) detected by monoclonal antibodies.

  1980cited by this paper
• Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: R.T.O.G. brain metastases phases I & II

  1978cited by this paper
• Treatment of meningeal neoplasms.

  1977cited by this paper
• Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.

  1977cited by this paper
• Therapeutic irradiation of the central nervous system using intrathecal 90Y--DTA.

  1976cited by this paper
• Dosimetry of several DTPA radiopharmaceuticals in cisternography.

  1975cited by this paper
• 169Yb-DTPA distribution and dosimetry in cisternography.

  1974cited by this paper
• Radiation dosimetry associated with the intrathecal administration of 131 I human serum albumin.

  1972cited by this paper
• Radiation dose in isotope encephalography.

  1968cited by this paper
• Radiation dose in isotope encephalography.

  1968cited by this paper

• Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors

  2023cites this paper
• Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies

  2022cites this paper
• A phase II study of radioimmunotherapy with intraventricular 131I‐3F8 for medulloblastoma

  2018cites this paper
• Primary diffuse leptomeningeal melanomatosis: Description and recommendations.

  2018cites this paper
• Leptomeningeal Metastasis as Complication of Systemic Cancers

  2018cites this paper
• Selection of novel affinity-matured human chondroitin sulfate proteoglycan 4 antibody fragments by yeast display

  2017cites this paper
• Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors.

  2013cites this paper
• Carcinomatous meningitis: Leptomeningeal metastases in solid tumors

  2013cites this paper
• Toxin-Based Targeted Therapy for Malignant Brain Tumors

  2012cites this paper
• Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab.

  2009cites this paper
• Molecular Targets for Antibody-Mediated Immunotherapy of Malignant Glioma

  2009cites this paper
• Prognostic factors and outcomes in patients with leptomeningeal melanomatosis.

  2008cites this paper
• Immunotherapy of malignant brain tumors

  2008cites this paper
• Leptomeningeal metastasis.

  2007cites this paper
• Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment.

  2006cites this paper
• Leptomeningeal metastases from solid malignancy: a review

  2005cites this paper
• Improving the outcome of patients with leptomeningeal cancer: new clinical trials and experimental therapies.

  2005cites this paper
• Leptomeningeal Metastasis

  2005cites this paper
• Radiation therapy for leptomeningeal cancer.

  2005cites this paper
• Immunotherapy of Central Nervous System Tumors

  2005cites this paper
• Monoclonal antibodies for brain tumour treatment

  2004cites this paper
• Human/murine chimeric 81C6 F(ab')(2) fragment: preclinical evaluation of a potential construct for the targeted radiotherapy of malignant glioma.

  2004cites this paper
• Leptomeningeal metastases

  2004cites this paper
• Specific and high-level targeting of radiolabeled octreotide analogues to human medulloblastoma xenografts.

  2003cites this paper
• Liquor-VEGF (Vasuclar Endothelial Growth Factor): ein neuer Tumormarker der Meningeosis carcinomatosa/VEGF (Vasuclar Endothelial Growth Factor) in Cerebrospinal Fluid: A New Tumour Marker for Carcinomatous Meningitis

  2003cites this paper
• Polytherapie a base de composes de boroproline

  2003cites this paper
• Leptomeningeal metastases.

  2003cites this paper
• Clinical immunotherapy for brain tumors.

  2002cites this paper
• NG2 precursor cells in neoplasia: Functional, histogenesis and therapeutic implications for malignant brain tumours

  2002cites this paper